Not available
Quote | Allena Pharmaceuticals Inc. (NASDAQ:ALNA)
Last: | $0.075 |
---|---|
Change Percent: | 14.53% |
Open: | $0.0641 |
Close: | $0.075 |
High: | $0.15 |
Low: | $0.06 |
Volume: | 276,971,676 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Allena Pharmaceuticals Inc. (NASDAQ:ALNA)
Buying Penny Stocks on July 29th? Here’s What You Need to Know If you’re looking for the best penny stocks to buy right now, there are hundreds of options to choose from. As a result, it all comes down to finding the best penny stocks that fit your trading strateg...
Allena Pharmaceuticals ( NASDAQ: ALNA ) on Tuesday said it had completed enrollment in the first two cohorts of its phase 2a study of its enzyme ALLN-346 in gout patients with stage 2 and stage 3 chronic kidney disease (CKD). ALNA is planning to enroll up to four cohor...
Message Board Posts | Allena Pharmaceuticals Inc. (NASDAQ:ALNA)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Allena Pharmaceuticals Inc. Company Name:
ALNA Stock Symbol:
NASDAQ Market:
Allena Pharmaceuticals Inc. Website:
Buying Penny Stocks on July 29th? Here’s What You Need to Know If you’re looking for the best penny stocks to buy right now, there are hundreds of options to choose from. As a result, it all comes down to finding the best penny stocks that fit your trading strateg...
NEWTON, Mass., July 19, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme the...
NEWTON, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorde...